<SEC-DOCUMENT>0001193125-19-009348.txt : 20190115
<SEC-HEADER>0001193125-19-009348.hdr.sgml : 20190115
<ACCEPTANCE-DATETIME>20190115070535
ACCESSION NUMBER:		0001193125-19-009348
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20190115
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20190115
DATE AS OF CHANGE:		20190115

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Edwards Lifesciences Corp
		CENTRAL INDEX KEY:			0001099800
		STANDARD INDUSTRIAL CLASSIFICATION:	ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
		IRS NUMBER:				364316614
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-15525
		FILM NUMBER:		19526182

	BUSINESS ADDRESS:	
		STREET 1:		ONE EDWARDS WAY
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92614
		BUSINESS PHONE:		9492502500

	MAIL ADDRESS:	
		STREET 1:		ONE EDWARDS WAY
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92614

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	EDWARDS LIFESCIENCES CORP.
		DATE OF NAME CHANGE:	20090225

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	EDWARDS LIFESCIENCES CORP
		DATE OF NAME CHANGE:	20000203

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVG CONTROLLED INC
		DATE OF NAME CHANGE:	19991126
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d689431d8k.htm
<DESCRIPTION>8-K
<TEXT>
<HTML><HEAD>
<TITLE>8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>WASHINGTON, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B><FONT
STYLE="white-space:nowrap">FORM&nbsp;8-K</FONT> </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>CURRENT
REPORT </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Pursuant to Section&nbsp;13 or 15(d)</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>of the Securities Exchange Act of 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Date of Report (Date of earliest event reported) January&nbsp;15, 2019 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>EDWARDS LIFESCIENCES CORPORATION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact name of registrant as specified in its charter) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Delaware</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="white-space:nowrap">1-15525</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="white-space:nowrap">36-4316614</FONT></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or other jurisdiction</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>of incorporation)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Commission</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>file number)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(IRS Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification No.)</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center"><B>One Edwards Way,&nbsp;Irvine, California</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>92614</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center"><B>(Address of principal executive offices)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>(Zip Code)</B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(949) <FONT STYLE="white-space:nowrap">250-2500</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Registrant&#146;s telephone number, including area code </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>N/A </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Former name or
former address, if changed since last report) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below
if the <FONT STYLE="white-space:nowrap">Form&nbsp;8-K</FONT> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Written communications pursuant to Rule&nbsp;425 under the Securities Act (17 CFR 230.425)
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Soliciting material pursuant to <FONT STYLE="white-space:nowrap">Rule&nbsp;14a-12</FONT> under the Exchange Act
(17 CFR <FONT STYLE="white-space:nowrap">240.14a-12)</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><FONT STYLE="white-space:nowrap">Pre-commencement</FONT> communications pursuant to <FONT
STYLE="white-space:nowrap">Rule&nbsp;14d-2(b)&nbsp;under</FONT> the Exchange Act (17 CFR <FONT STYLE="white-space:nowrap">240.14d-2(b))</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><FONT STYLE="white-space:nowrap">Pre-commencement</FONT> communications pursuant to <FONT
STYLE="white-space:nowrap">Rule&nbsp;13e-4(c)&nbsp;under</FONT> the Exchange Act (17 CFR <FONT STYLE="white-space:nowrap">240.13e-4(c))</FONT> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule <FONT
STYLE="white-space:nowrap">12b-2</FONT> of the Securities Exchange Act of 1934 (17 CFR <FONT STYLE="white-space:nowrap">240.12b-2).</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging
growth company&nbsp;&nbsp;&#9744; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition
period for complying with any new or revised financial accounting standards provided pursuant to Section&nbsp;13(a) of the Exchange Act.&nbsp;&#9744; </P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="12%" VALIGN="top" ALIGN="left"><B>Item&nbsp;7.01.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Regulation FD Disclosure. </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On January&nbsp;15, 2019, Edwards Lifesciences Corporation, a Delaware corporation (&#147;Edwards&#148;), jointly with Boston Scientific
Corporation (&#147;Boston Scientific&#148;), issued a press release announcing that Edwards and Boston Scientific have reached an agreement to settle all outstanding patent disputes between the companies in all venues around the world. A copy of the
press release is furnished as Exhibit&nbsp;99.1, and is incorporated herein by reference. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In accordance with General Instruction B.2 of <FONT
STYLE="white-space:nowrap">Form&nbsp;8-K,&nbsp;the</FONT> information in this Item 7.01, including Exhibit 99.1, shall not be deemed to be &#147;filed&#148; for purposes of Section&nbsp;18 of the Securities Exchange Act of 1934, as amended (the
&#147;Exchange Act&#148;), or otherwise subject to the liabilities of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act,
except as shall be expressly set forth by specific reference in such filing. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="12%" VALIGN="top" ALIGN="left"><B>Item&nbsp;9.01.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Financial Statements and Exhibits. </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Exhibits</B> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="94%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d689431dex991.htm">Press release, dated January&nbsp;15, 2019, announcing a settlement agreement between Edwards and Boston Scientific. </A></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="46%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: January&nbsp;15, 2019</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"><B>EDWARDS LIFESCIENCES CORPORATION</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Scott B. Ullem</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Scott B. Ullem</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Chief Financial Officer</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d689431dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="33%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em">


<IMG SRC="g6894311.jpg" ALT="LOGO">
</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">


<IMG SRC="g6894312.jpg" ALT="LOGO">
</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>FOR IMMEDIATE RELEASE </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Boston Scientific contacts: </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Media
</B><B>Relations</B><B>:</B><B> </B>Trish Backes, 651-582-5887 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Investor </B><B>Relations</B><B>:</B><B> </B>Susie Lisa, CFA, 508-683-5565 </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Edwards Lifesciences contacts: </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Media
</B><B>Relations</B><B>:</B><B> </B>Sarah Huoh, 949-250-5070 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Investor </B><B>Relations</B><B>:</B><B> </B>David K. Erickson, 949-250-6826 </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>BOSTON SCIENTIFIC, EDWARDS LIFESCIENCES AGREE TO </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>GLOBAL LITIGATION SETTLEMENT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>All Patent Litigation Between the Companies to be Dismissed </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>MARLBOROUGH, Mass., and IRVINE, Calif., January 15, 2019</B> &#151; Boston Scientific Corporation (NYSE: BSX) and Edwards Lifesciences Corporation (NYSE:
EW) today announced that the companies have reached an agreement to settle all outstanding patent disputes between the companies in all venues around the world. All pending cases or appeals in courts and patent offices between the two companies will
be dismissed, and the parties will not litigate patent disputes related to current portfolios of transcatheter aortic valves, certain mitral valve repair devices, and left atrial appendage closure devices. Any injunctions currently in place will be
lifted. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the terms of the agreement, Edwards has made a <FONT STYLE="white-space:nowrap">one-time</FONT> payment to Boston
Scientific of $180&nbsp;million. No further royalties will be owed by either party under the agreement. All other terms remain confidential. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>About
Boston Scientific </U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the
world.&nbsp;As a global medical technology leader for more than 35 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information,
visit&nbsp;<B><U>www.bostonscientific.com</U></B> and connect on <B><U>Twitter</U></B> and <B><U>Facebook</U></B>. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>About Edwards Lifesciences
</U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Edwards Lifesciences, based in Irvine, Calif., is the global leader in patient-focused medical innovations for structural heart disease, as well
as critical care and surgical monitoring. Driven by a passion to help patients, the company collaborates with the world&#146;s leading clinicians and researchers to address unmet healthcare needs, working to improve patient outcomes and enhance
lives. For more information, visit <U>www.Edwards.com</U> and follow us on Twitter @EdwardsLifesci. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g6894311.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g6894311.jpg
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MQ "S    !04!                !@<("0$"! 4* P$  00# 0
M      $"!@<#! 4($   !@$!!P(#!00) 0D    ! @,$!08'"  1$A,4%18A
M"3$B%T%1)!@*87$R(X&1H;'10C,E)D/PX5)R-#8G*1H1  $"!0,"! 4"!0,"
M!P    $1 @ A P0%,1(&00=182(3<8&1H3)"%+'14B,5P6(S\19R@F-S%S<8
M_]H # ,!  (1 Q$ /P#OXV((&Q!%!#?_ %AL0A"_6.=O]2'BS'0:"+?FT:76
M0R]"WC#=2ALF=H:A=HJL/+WO=5]C82IA)MHAR:27YB!% 3/SC[P'>.UP=CKJ
M[I<XM[052VBYE20"@E.HBG.]]G;5>%UKT4]UPVHP*I"">GV@IX+]MS25GOVC
M\!Y E*'"XRS8&DZ&R1%:B*$Y>4?)<!D!C2E)LEUE;3 .&;R=*9ZT SXCX'!5
MD!4 .$XE.76R/-<[B>?W-BZX-?'U,@6OMWC^W6&] #T:@4-ZS,/QO$,%D>WU
M"]-L*=X+#<*BE6D,)77J1!Y_3H:P<^ZI]).0F.?+!*WZ0PODUK1JGD^=4.YF
M;17)"K,)TL1,RZB93SDA5%EP3!TJ<[H[9R@583"0#FR=Y>-XSCO(J53'4A0_
M=6HK5*(TI/+G M'D@!\/",G9S/9',X&K0R-4UG6UP:3'$?I#00U>J=.J$1T+
M%.0P;RF*8-X^I3 (>@B ^H>GH.U2 @A1,1;IU3K XR#\#E'X?Y@^WX?;]N_9
MNYNT/4;#UZ?6 $%Q8/S&HZCY143%#XF /3?ZB >@?'95U F1!U ZF$)R)G^E
M8XRO@3#DLH9Q==0=@N<13XUNX;%708T.CS5YLMA>MU3@N:(8MHQ!H)TRF'JW
MR(#\HF$-BWM*]S9U,@R5K2 +B1(*4 713X1S;K)VMI>T;"JAN:Q1H6?Q35/-
M$A=>(H_ Q1^SXA\?NVP:S&D=%1 $Y '<)R@(AOW"8 '<'Q'=O^ ;(7-#@PD;
MR%3J@U*0X N&YLV^, 3D#XF*'[S!_CL.<&MW.(#?$Z0GEU,5XBANWF#UW;O4
M/7?\-WW[]@N: I( @ZIUBOQV6$!!T@;$+ V((&Q! V((&Q!%!'< B/P -X_T
M;(2&@DZ" 3E%O&3=OX@_NV::C&M#G%&D+\H!ZB0V9!0Q7C+_ .(/0=P_O#X[
M.) 1>L("#(>*1 U^I$, ^UQ?Q_B ,MX1WA^SSIB.UN=D?_L*U_\ ;>?M%2][
M"O +D H159_K*&X8MT8:OM3/M!:::IB[5Y.Q-=L&FVE/#X&6I53IE?R#6CP"
M3@F()G,E40;Y*KL+-($Z-1^DHLHH4^YP4R9C[DN.28+C_<F\OLE9^XW]^]K7
M_F:3W/(%44W>EVT^I#(=#&I8<>SF6[>65"RO2T?L9L  W! =JB9T28C5^WW[
MI6F/$?MK:F#XPTYM=/M[T+5EZ]O6GY"<?V-A8[M99I2G5^QDO#\ L<\G9LAD
M(QF%WXG?LE"<',.CR#[=#EO ,_D><V%&^O/WEMEZX]NY&CVD+MVG\2!^D!)C
MSC3X?S;$X[A5\;.U%"_Q=+ULZO>4;[Q^)(!Z^GX0ZK0'@JV:W-&6.]56H_/&
MH1UG_/\ '6R[1%CQQF7(&+JQA9F\L,Y#U"$Q=CREV*+I#2.@8N.;JF[DQD%G
MRIC@[,L41+M%.6W5EQGE57$8VVI?MK*HVD6/:'%R(VHYQ/BY?ATB3\6Q][R#
MC-/.7US5_P I<,=4:6N0 $G8 /\ :-881B_W<L^6OVU=6+V[V&6>9\T<YRQU
MAC+V9:%"QJ5M?8+M>5FM.G<TPT"* 0\9D&/J\9,-@< B5HC()HO1(41,!93?
M]O+&WY=8T+,M;9Y*U;7ILJ?\8K.;N]IODJ:IX+$7LN>W]3BUX+D/?D+"Z-%[
MJ?\ RFD-:KO/I(^:0]7!.6-%6?LM:=%]!>O>VKV.%R,QM^7L&7S/N8)>1S1C
MTE5M#.:92U&S"\DI=Y=XB;=M)$21PH)KIME.I Z0)"2/9WC_ "K!6UT.58L4
MFDHRK38U&D$;?4Q1M(E/Y&)#A<OQO+7=I2XQDW&X))?3JN=N<T@K^0 W:Z=3
M$;T]B=S_ /I0IV&E<Q9]>PS#$3^3A;5*Y=LLUD*NA.X.L%HE8RN6J84?K0<"
M\E!,!F;5-)#E&,0"@ [3BSJMI]D*V2;;VQJ.R :[T#^H(HB%WU@:W>6G8FXN
M6TFV@+2'HX>A9'IJ>D/PR/J+OV:_=-QE[4-(RUE2G8/PYBV2ONH6\0]QE&&:
MLQ6)I56EMB:&]RJR".L\!76S6R1IG[F,4;/'W&JESR$(4-H;8X6RQO 7\UOJ
M8J96O7-*DQ![=(*07.'4HNWP*1++GD%WE>=C@F/J[,5;T@ZL]3[CSMW(">J[
M0=9+&'KES;-^TEJ2T8SE%R#D^7TLZE+9:,59LQ!D3(-NRDVJIV:U72C\IXOL
MM]F+#;JG88DEK,L[9I/#,'B34=Z *F ^V?AN$H\UX_DZ-6E3;FL?3%6C4:/4
MYD_[9 0$.10NB:QAY7E'<+SEB^G6K'!W3C2>PNEN4+4'ALD#YGP,-KRED#5Q
M">^A1-#F+]7.:XK$D]C!A) -YLQ+ZO6PL&,['8KE985I*QY8R6N2#&+.2"/*
MI/&,8]5*XY"G*!,W:QF)XV_M#<\BOK0/RU.Z#&N  $B$#CKH0O\ I'$RM]G6
M]T;?CV/O*K<=4I->0]Q<=I:IV=-5\--91K-=S7(?MB^XW[?,_@+4)J0L5<U+
MW9*L9KHF9<SV_*];N;-*_P!$K$FX6;6QX\08.9:.O"BH V31(S=-$E&P)@)B
M;9^'V]AS3AF8_P I:T&W-A0]VB^DP-( 82 4U((D2JJ5C'S&OD.'<WQ;\7=5
MW6U]4#*K:CMRJ\ D2'I34>/QEUPE4(4#<0@7A,8!_8 "(@(_T;4/O +6O/K>
M2GFD7^UOZ6A! YR6[?QANW[O7>'V;_3>'KZ;)[K-H<OI)3YP=%EHORCT 0$
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M!883L9,<N[/:JQ%OKC"HUR6=JU!_VZ3DPC5';I5C'+."F,B*QDU13+Q'(3X
MW/8+*\8R?^%R_IO2UA#023ZV[@- I0P_ 9[$\AQO^;QK5M YXW. ";"A,B4'
M6$/K_N043*#S([K39@O.FI_'N([!+U*_Y9Q)%T).D'LL V(YG:]CIQ=[W497
M*\O$%4*"X0C9RW$QBE265.8I#;;^+W-G2IMRM>G:W=0 M94+MY!T<4!V@^?T
MCGMYE;73WG&6U:ZM*3D=48&[%&J*9CZ0IF/M=>!\R8'B-1&#F>0\WT>6G5JW
M(1>+:')V#(%3L<>@NK-0]XI"PQ\W5Y*OG1!-XFY*4R9U4A+QD5(<>?D,)D[&
M_P#\5D6^T[:"TD^EX.A:>H/P^\=2PSV*N[ Y;&@U&@D.:T O:BKN"A$^/UAK
MV)?><TBZAV%F3P17<U9=N,-9VE1K>+:[C84\C7R>&*4EYA[!5Z9E6"4'3JBW
M*D25L,ZO$P[1=8B0.#J'3(?O93@/(,!6H.S*6MM7I>XUY<=@;\@I/^T*L1^R
M[@\>S;*HQK77=W2*>VU@WD]$!*#XDP<<#^Z-BW*FJ.2T7Y5P]EW2[J;1A3V.
MN8]S&UI[EE>X#MQI55S4+A1;/:JW*..V-UUP1YY>:DV6Y9CG24(1V3X-?V&$
M9R?&W%*^PI(%2I2W#VG$HT/#PTA7$"2S,9L7SBTR>7?QR]MJMKDPWTLJ[?4$
M4HG^W22'QA@/NJ^ZM+XFGL,Z6:'A?4-0;?ES.>,47M^L%:)3$)C'%0S#4E+B
MQQ,S8S;BQVV5N1VR<:F84F**C-Z;A.<5BEV['#N"NSV-O\_?75(T[.W<C 7?
MF@V[I(  JZG3I$;YASI_&LC:<<QUI595N+AJO<&[2P[@X,FI4HF@D>L3,+:K
M(YO09O(CW!>IY@P@9M"&=UQWAR41NBR"L8YE5[&QKG<#.'-5CD6HI.7I3@5)
M<Q4^$1$-J]&,<^X%)M=A>^4G^D>$TU/WBQ79FG2MGW=6WKMITPJ%GKZJ0%,@
M-5(2$ITC>Y#I]UQX_P QY.T[L,GVBJX6E4H.8*ZH[F*L-IF#UI.TBPIE7<O.
M[RSH6BI4$R+)MC+.AX" )=QAZ_(N(YCC'[5F4#:=:Y9O8%)&P.VJ=)G^'6-'
MCW+,5R6G7KXH&I0H/#7* I<B^F9_B)QS<2>?%)+]2M#92=8OSB9")QNC",,<
MGQN\#+*#(NGI\F!0HH/ >"S%])+/.:*H_A#\WX>FUW4<?29V"N=M6C[INR20
M20?[C>J3*#3Y12-7(5*_>NC6?1KAM.B&AA:-_P"#D**1U772)ZM1?N]Z<-*,
M- S.><6ZI,>#<W[Z%I#.RX-E8E6W3#!)HL[BHMX[E21B*B"3Q(ZAW*R"12&W
M[Q$-VU,X/@^7Y'6></[%6K;4-[W!_P"-,:[D"J4D/&+@S/-L5Q^@U^6;<T6U
MJVUK7,"N=*;?4B!0LR?*</,U,:N<"Z/\2CF7/MT0I=0.M'QD,U3:.9>S6JPR
MB8&BZK3ZQ%)N9>RV)_Z\MLU2.)2E,<XD3*8X<G&8?(9B]%CCZ>]\U.C6 =7'
MH([>3SN/Q%D+^_?M8X M$MSR>C0H4^,PD-RL?N25?%E:KF2-1^G?4+IJPS;)
MZMUZ-RSE*+QXK!U]];G"3.N&R5 4O(5JN6.6TH^731!5_'BFV4. .S-_7=TJ
M?&JMX\V^)KT;N^:TDTJ>_<C0I3<T _(QR:O+:-E3;<Y>VKVEDYP J5-FU7:*
MCB1$B[%^VD6S=XS53<-722:[9P@JDN@X;KIE60<(+(G.DL@NB<#D.41*8H@(
M"(#M%]SP2Q['-J-=M<#JTCQB6AU-S65*;@ZD]H<UPT(/A&;L^%BAM_";=\=P
M[OW[O38@0&1T,,DQ[D?$^L]75)A;(N-J5:(O V>YG"%PI-P915VAIQ)E4JI;
MZ_:GL++QHMV1YF.M)@33$AQ24;'$BHC\.K6H7W':MG>XY]2D;R@:HJ-5J.:X
MM+0A"Z$JH^$1BVKVO)A=660HTZC;2Z=2V&?I&CY]2FGWB-'6=^G>T-YNH%L?
M:?Z,EIPS*$7).ZG*4>1E Q_+3_+579P]MHLF]?PR<')N1! ZL:5BX:E.!R"8
MJ?*-/N-]W^78*HUE]<.N[ R=3J$S!D@/J/\ &(=R?M'Q?-4'U+*BVVO0%:Y@
MT+5.BB( LE:D\[J?IWZYBVR25@!.%UK2VE^8F7#M5P9SC*@P;[(<=3EI$"F,
M]@XNU($C" 8YBBWCR(;Q3#@VN''\=P/_ ,T?N;%K!1;BVW(8DA6>&J/D"2J:
M](J+(YK,T^SM.WNB]U1]^:1<I7VVSV_7S\H[ -*>$J+=?;+T_8*=(/X:A7_1
MKCVF3B==D%XN8;QF0,41B=B=14JF)UF,LX6FG"Q%]Q^%8XB("&\-O-F=RUU:
M\MN<QN:<E2OWO:2T%"U^B'X#^4>A^-XZA=<,M,<QI995K!K"ATW-F5ZS),,_
MU!:,L0:#/9@UBZ>L*.;-(T^*PCF6SNI:Y2S:9LDQ8;-'F<R<A)NF#&,C4S<I
M%!)))NU02321+\HF$QC2+$Y_(<I[E8S.Y@K=ONJ81OI&T.9+^,_-(CV4X_8\
M7[>Y+#XPK09;/<2Z9+R"I\I!LO)>L13:2<C6[%/Z87/]SHLDXAK(@^S'76LL
MU-PNXYC=\L0=+FW#5<#)G;N>Q6!R1-4H\29S 8/4-K,Y=C;;*]^K>TOW#]NX
MTG;C/;MIJUJ=5(U41 >*WU?']D*MS:?\O]YKD_W/0GRE+YP\OV*\?:K"^VSA
M1_B',F"JC2I*R93E&-=NV!K7=; S='R+/M9#J[+"YMI;-\DLX:"9("QZ)T43
M%()CB7BVB7=RXPCNX=U_D+:JZM2IA@VU0T AC?4 6.DB*WQ5#.))VGHYT\(H
MU;2YIMHO<[TFGN*DS)=N"D^8AYWMR^VK/>WY,:LY^3U!$R\349,HW^3K#*D>
M$PU1LZ;BYR,I(QS$ULM"BQ)9.QD;%$YDSE08IE,93=O+'.3\TI<P;B*8M11=
M9@4_<W;C4 V@+Z0B;?$ZQW>,\,J<5_RSQ=>Z+IA<&;-H8=KBOY%=? 2B)_\
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M]*0/ZJ+?LP_R@Q_JHO\ V%H7W#P__,V1A^([Q_X]4/B._P#8&VGV!:'7N:H
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M[//G#9TS(J*A(E<4"*"<H''K6O<>^MN=-YH:.YA<&/IL4-;2#=J!23H 3/\
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M &,&@'T_AX?*+N OW?VCLXM!"0I (0Z1:;EIE,8P@4I2B8QC&W !0^(B(B
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..Y]D/G"A.D+KLDH(__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g6894312.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g6894312.jpg
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MQ "J   " @$% 0             '" 8)"@ " P0% 0$! 0$! 0$
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MFO0\?9,G9JE6A)IJG(5FAUVG4%&WV"-5'EM-RD@_KB["F5E[P/N[A=!R\>%
M3(-A3X6ZE-).P_3'D=R$]3[:FPV>JUR$5IC%K+6"$@RH/:\$Y*O?E27:LO\
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M3IQC37JESE>LV(%;#+7BEW>&FI1^:L3&2X>285E>/CU#MW+@$UE!$H&1()A
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?J= :#['_  O[4_0&[X?X4OTE.@. GV0?K5/U.@/_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
